← All trials
NCT06445062
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 24, 2024
- Primary completion
- May 15, 2027
- Completion date
- Jul 15, 2027
- First posted
- Jun 6, 2024
- Last posted
- Nov 26, 2024
- Enrollment
- 406
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Revolution Medicines, Inc.Lead sponsor
- Revolution Medicines, Inc.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.